Company Filing History:
Years Active: 2014-2025
Title: Bruno Frédéric Stengel: Innovator in Oligosaccharide Technology
Introduction
Bruno Frédéric Stengel is a notable inventor based in Auderghem, Belgium. He has made significant contributions to the field of oligosaccharide technology, holding a total of 4 patents. His work focuses on innovative compositions and processes that have potential applications in both human and animal treatments.
Latest Patents
Stengel's latest patents include a composition comprising mannose oligosaccharide and a process for making the same. This invention relates to a composition that can be utilized in the treatment of humans or animals. Another significant patent is for the epimerization of saccharides, which involves a process conducted in a microdevice with a network of micron-sized channels. This process utilizes a molybdenum-containing catalyst and is aimed at the epimerization reaction of saccharides, leading to the oligomerization of the resulting epimerized saccharide into manno-oligosaccharides.
Career Highlights
Throughout his career, Stengel has worked with prominent organizations such as Cargill Inc. and the Karlsruhe Institute of Technology. His experience in these institutions has allowed him to develop and refine his innovative ideas in the field of oligosaccharides.
Collaborations
Stengel has collaborated with notable individuals in his field, including Marc Charles Florent Berckmans and Rita Delrue. These collaborations have contributed to the advancement of his research and inventions.
Conclusion
Bruno Frédéric Stengel is a distinguished inventor whose work in oligosaccharide technology has the potential to impact various applications in medicine and beyond. His innovative patents and collaborations highlight his commitment to advancing scientific knowledge and practical solutions.